Business Wire

Transformative Tech Unveiled at CES Asia 2018 on Opening Day

Del

CES Asia® 2018 opened today, with more than 500 global companies introducing transformative innovation, including the latest in 5G, artificial intelligence (AI), augmented/virtual reality (AR/VR), vehicle tech and more. Opening day of Asia’s premier tech event featured keynotes from the leaders of Hisense, Huawei and BYTON, and major product announcements designed for the dynamic Asian marketplace. One of Asia’s fastest growing tradeshows, CES Asia 2018 runs through June 15 in Shanghai, China.

Gary Shapiro, president and CEO, Consumer Technology Association (CTA)TM, kicked off the day with a keynote address. “We’re proud to bring the entire tech ecosystem together this week in Shanghai to focus on the future of tech,” said Shapiro. “The innovations on the show floor create disruption, but also provide solutions. Self-driving vehicles can stop fatalities; AI is making us safer and healthier and drones are helping in disaster relief.” He continued, “CES Asia focuses on what unites us rather than on what divides us.”

Following Shapiro’s remarks, Hisense Chairman Zhou Houjian and General Manager Yu Zhitao explored the future of display technology explaining how Hisense is creating a full-field view search interactive function, opening a new era of television image interaction. Zhou also touted its new AI technology developed specifically for the World Cup, which will provide an individualized, interactive experience for sports fans across the world.

Huawei, President, Handset Product Line, Mr. Kevin Ho, took the keynote stage in the afternoon to introduce its vision for a new image era in mobile technology, including its cutting-edge lens technology, 5G internet capability and the advanced GPU Turbo processor. Ho also launched Huawei’s “Next Image Awards,” competition.

CES Asia 2018’s first day ended with BYTON President & Co-Founder Dr. Daniel Kirchert and Henrik Wenders, vice president of Marketing, using the keynote stage to share the company’s vision of the future of self-driving cars. The session also marked the global reveal of BYTON’s K-Byte Concept car, which will transform the auto industry in the age of smart mobility.

The buzz around tech breakthroughs expanded beyond the keynote stage. In his 2018 Tech Trends to Watch presentation, Steve Koenig, vice president, CTA, predicted how leading trends, including AI, voice computing, robotics, self-driving vehicles, smart devices and more will impact our lives and offer unprecedented opportunities. CTA’s Market Research Director, Lesley Rohrbaugh, also tackled the future of smart cities and how they are evolving throughout Asia with a specific focus on China, Japan and South Korea.

Pre-show and opening day of CES Asia featured a wide array of dynamic press events, with exciting product and partnership announcements coming from CES Asia exhibitors, aimed at improving the user experience and bettering lives:

  • BYTON launched its second concept car, the Byton K-Byte, designed for the age of self-driving and in-vehicle entertainment
  • Cadillac presented the Super Cruise, the first hands-free driving system for the highway
  • Honda announced the Honda Xcelerator project, which aims to cooperate with innovative enterprises worldwide
  • Kia announced its Boundless for all vision, which aims to provide customers with broader solutions and reinforce its concept of “Mobility-ACE”
  • Leapmotor Technology announced a strategic partnership with the Amap and Teld. Amap will provide support to Leapmotor inhardware, software, and big data, while Teld and Leapmotor Technology will jointly build 80 million charging stations in China
  • The Mercedes-Benz - MBUX, user experience system based on artificial intelligence technology, as well as high-resolution Digital Light system with more than two million light sources. With its new vision of urban mobility, the smart vision EQ fortwo was on display with the Concept EQ, showcasing intelligent, electric mobility concept
  • Mitsubishi offered attendees the unique opportunity to experience three of its innovative offerings, including EMIRAI4, Electrification and xAuto
  • SENSEPLAY FPV Car Series took the number one slot in Last Gadget Standing, presented by Living in Digital Times

The CES Asia 2018 conference program tackles technologies ranging from 5Gconnectivity to blockchain and runs through Friday, June 15 at the Shanghai New International Exhibition Centre (SNIEC) and Kerry Hotel. For the latest news, photos, b-roll and more, visit CESAsia.com.

Owned and produced by International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex, CES Asia 2018 concludes June 15, in Shanghai, China. The premier event for the consumer technology industry in Asia, CES Asia showcases major brands and innovative companies across several vertical markets in the Asian marketplace.

About CES Asia:

Owned and produced by the International CES (Shanghai) Exhibition Co. Ltd. and co-produced by Shanghai Intex Exhibition Co., Ltd (Shanghai Intex), CES Asia is the premier event for the consumer technology industry, showcasing the full breadth and depth of the innovation value-chain in the Asian marketplace. Key global businesses come to this new event to grow and reinforce their brand by showcasing the latest products and technologies to consumer tech industry executives, foreign buyers, international media and a limited number of consumers from China. Attendees have exclusive access to some of the largest brands from China and around the world, while celebrating the innovation that defines the consumer technology sector.

About International CES (Shanghai) Exhibition Co. Ltd. and CTA:

International CES (Shanghai) Exhibition Co. Ltd. is a wholly foreign-owned enterprise by the Consumer Technology Association (CTA), a trade association representing the $351 billion U.S. consumer technology industry, which supports more than 15 million U.S. jobs. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. CTA also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.

About Shanghai Intex:

Shanghai Intex Exhibition Co., Ltd was originally the exhibition organizing business of Shanghai Intex, a pioneering exhibition organizer established in 1995. Shanghai Intex is jointly overseen by the China Council for the Promotion of International Trade (CCPIT) Shanghai and PNO Exhibition Investment (Dubai) Limited. Starting in 1998, Shanghai Intex has organized over 100 trade shows and conferences with a sum total exhibition space in excess of 2 million sqm. Shanghai Intex is comprised of professional teams with a wealth of experience in organizing major international events, covering the creative industry, healthcare, lifestyle, advanced manufacturing and consumer electronics.

UPCOMING EVENTS

  • CES Asia 2018 – Register
    June 13-15, Shanghai, China
  • CEO Summit
    June 24-27, Barcelona, Spain
  • CES Unveiled Amsterdam
    September 27, Amsterdam, Netherlands
  • Tech & Standard Fall Forum
    October 1-5, Hollywood, CA
  • CES Unveiled Paris
    October 3, Paris, France
  • Innovate Celebrate
    October 15-17, Boston, MA
  • CES Unveiled New York
    November 8, New York, NY
  • CES Unveiled Las Vegas
    January 6, 2019, Las Vegas, NV
  • CES 2019
    January 8-11, 2019, Las Vegas, NV

Contact information

Consumer Technology Association
Teresa Hsu, 703-907-5259
thsu@CTA.tech
www.CESAsia.com
or
Bernice Morquette, 703-907-7651
bmorquette@CTA.tech
www.CES.tech

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00Pressemelding

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10Pressemelding

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13Pressemelding

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00Pressemelding

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41Pressemelding

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00Pressemelding

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i